The pricey Evzio auto-injector, which is used to administer opioid overdose antidote naloxone, will come in a generic form next year at a price of $178, compared to the current brand-name price of $4,100, drugmaker Kaleo announced.
Generic drugs are typically introduced after the patent on a brand-name medication expires. But the Evzio generic will be available in mid-2019, “well in advance of Evzio’s patent expirations,” Kaleo said in a news release on Wednesday. The generic will be offered through Kaleo subsidiary IJ Therapeutics.
Kaleo has come under fire for its steep p...
Comments